Vimpat (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the Vimpat drug offered from REMEDYREPACK INC.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
NON-PROPRIETARY NAME: | lacosamide |
SUBSTANCE NAME: | LACOSAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
Vimpat HUMAN PRESCRIPTION DRUG Details:
Item Description | Vimpat from REMEDYREPACK INC. |
LABELER NAME: | REMEDYREPACK INC. |
DEA SCHEDULE: | CV
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70518-0257_5d80e6a5-d99b-c5b2-e053-2a91aa0a3343 |
PRODUCT NDC: | 70518-0257 |
APPLICATION NUMBER: | NDA022253 |
Other LACOSAMIDE Pharmaceutical Manufacturers / Labelers: